CAS 1192347-42-4

TAK 259

CAS: 1192347-42-4

TAK 259 is a drug that belongs to the group of antagonists. It has been shown to inhibit primary tumor growth and bladder cancer by blocking the angiogenic process. TAK 259 inhibits tumor vascularity and cellular proliferation by inhibiting the production of vascular endothelial growth factor (VEGF). This drug also inhibits cancer cell migration and adhesion. TAK 259 is administered via a specialized osmotic pump, which delivers a fixed dose of the drug directly to the site of cancer cells. In this way, it bypasses healthy tissue, minimizing side effects.

Fórmula: C₁₄H₁₄Cl₃N₃O₃S

Pureza: Min. 95%

Peso molecular: 410.7 g/mol

Ref: 3D-SXB34742

TAK-259 HCl

CAS: 1192347-42-4

TAK-259: selective α1D blocker, oral, treats OAB symptoms, anti-frequency, Ki=1.1 nM, low HERG impact.

Fórmula: C₁₄H₁₄Cl₃N₃O₃S

Cor e Forma: Solid

Peso molecular: 410.7

Ref: TM-T34774